 | • レポートコード：MRC2102QY9873 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の核医学/放射性医薬品市場について種類別（Tc-99、I-123/131、In-111、Xe-133、Th-201、Ga-67、その他）、用途別（診断、治療）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・核医学/放射性医薬品市場の概要 ・世界の主要地域別核医学/放射性医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の核医学/放射性医薬品市場規模2015-2026：種類別（Tc-99、I-123/131、In-111、Xe-133、Th-201、Ga-67、その他） ・世界の核医学/放射性医薬品市場規模2015-2026：用途別（診断、治療） ・核医学/放射性医薬品の米国市場規模2015-2020 ・核医学/放射性医薬品のヨーロッパ市場規模2015-2020 ・核医学/放射性医薬品の中国市場規模2015-2020 ・核医学/放射性医薬品の日本市場規模2015-2020 ・核医学/放射性医薬品の東南アジア市場規模2015-2020 ・核医学/放射性医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・核医学/放射性医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・核医学/放射性医薬品の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Nuclear Medicine/Radiopharmaceutic Market
The global Nuclear Medicine/Radiopharmaceutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Nuclear Medicine/Radiopharmaceutic Scope and Market Size
The global Nuclear Medicine/Radiopharmaceutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine/Radiopharmaceutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Nuclear Medicine/Radiopharmaceutic market is segmented into
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Segment by Application, the Nuclear Medicine/Radiopharmaceutic market is segmented into
Diagnostic
Therapeutic
The Nuclear Medicine/Radiopharmaceutic market is analysed and market size information is provided by regions (countries). Segment by Application, the Nuclear Medicine/Radiopharmaceutic market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine/Radiopharmaceutic Market Share Analysis
Nuclear Medicine/Radiopharmaceutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine/Radiopharmaceutic business, the date to enter into the Nuclear Medicine/Radiopharmaceutic market, Nuclear Medicine/Radiopharmaceutic product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
1 Nuclear Medicine/Radiopharmaceutic Market Overview
1.1 Nuclear Medicine/Radiopharmaceutic Product Scope
1.2 Nuclear Medicine/Radiopharmaceutic Segment by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2020-2026)
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Nuclear Medicine/Radiopharmaceutic Segment by Application
1.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Comparison by Application (2020-2026)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2026)
1.4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2015-2026)
1.4.3 Global Nuclear Medicine/Radiopharmaceutic Price Trends (2015-2026)
2 Nuclear Medicine/Radiopharmaceutic Estimate and Forecast by Region
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
2.3 Global Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2015-2026)
2.4.2 Europe Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2015-2026)
2.4.3 China Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2015-2026)
2.4.4 Japan Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2015-2026)
2.4.6 India Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2015-2026)
3 Global Nuclear Medicine/Radiopharmaceutic Competition Landscape by Players
3.1 Global Top Nuclear Medicine/Radiopharmaceutic Players by Sales (2015-2020)
3.2 Global Top Nuclear Medicine/Radiopharmaceutic Players by Revenue (2015-2020)
3.3 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2019)
3.4 Global Nuclear Medicine/Radiopharmaceutic Average Price by Company (2015-2020)
3.5 Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nuclear Medicine/Radiopharmaceutic Players (Opinion Leaders)
4 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type
4.1 Global Nuclear Medicine/Radiopharmaceutic Historic Market Review by Type (2015-2020)
4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2015-2020)
4.1.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2015-2020)
4.2 Global Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2021-2026)
4.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2021-2026)
5 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application
5.1 Global Nuclear Medicine/Radiopharmaceutic Historic Market Review by Application (2015-2020)
5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2015-2020)
5.1.3 Global Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
5.2 Global Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2021-2026)
6 United States Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
6.1 United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
6.2 United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
6.3 United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
7 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
7.1 Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
7.2 Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
7.3 Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
8 China Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
8.1 China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
8.2 China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
8.3 China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
9 Japan Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
9.1 Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (3015-3030)
9.2 Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
9.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
10 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
10.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
11 India Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
11.1 India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
11.2 India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
11.3 India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceutic Business
12.1 GE Healthcare
12.1.1 GE Healthcare Corporation Information
12.1.2 GE Healthcare Business Overview
12.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
12.1.5 GE Healthcare Recent Development
12.2 Bracco Imaging
12.2.1 Bracco Imaging Corporation Information
12.2.2 Bracco Imaging Business Overview
12.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
12.2.5 Bracco Imaging Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Lantheus Medical Imaging
12.4.1 Lantheus Medical Imaging Corporation Information
12.4.2 Lantheus Medical Imaging Business Overview
12.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
12.4.5 Lantheus Medical Imaging Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Products Offered
12.5.5 Bayer Recent Development
12.6 Jubilant Pharma
12.6.1 Jubilant Pharma Corporation Information
12.6.2 Jubilant Pharma Business Overview
12.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products Offered
12.6.5 Jubilant Pharma Recent Development
12.7 Nordion
12.7.1 Nordion Corporation Information
12.7.2 Nordion Business Overview
12.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Products Offered
12.7.5 Nordion Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Business Overview
12.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products Offered
12.8.5 Eli Lilly Recent Development
12.9 SIEMENS
12.9.1 SIEMENS Corporation Information
12.9.2 SIEMENS Business Overview
12.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Products Offered
12.9.5 SIEMENS Recent Development
12.10 China Isotope & Radiation
12.10.1 China Isotope & Radiation Corporation Information
12.10.2 China Isotope & Radiation Business Overview
12.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
12.10.5 China Isotope & Radiation Recent Development
12.11 Yantai Dongcheng Biochemicals
12.11.1 Yantai Dongcheng Biochemicals Corporation Information
12.11.2 Yantai Dongcheng Biochemicals Business Overview
12.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Products Offered
12.11.5 Yantai Dongcheng Biochemicals Recent Development
13 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
13.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
13.4 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nuclear Medicine/Radiopharmaceutic Distributors List
14.3 Nuclear Medicine/Radiopharmaceutic Customers
15 Market Dynamics
15.1 Nuclear Medicine/Radiopharmaceutic Market Trends
15.2 Nuclear Medicine/Radiopharmaceutic Opportunities and Drivers
15.3 Nuclear Medicine/Radiopharmaceutic Market Challenges
15.4 Nuclear Medicine/Radiopharmaceutic Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Nuclear Medicine/Radiopharmaceutic Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Region (2015-2020)
Table 5. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Table 6. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Region (2015-2020)
Table 8. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Forecast by Region (2021-2026)
Table 9. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Nuclear Medicine/Radiopharmaceutic Revenue Share Forecast by Region (2021-2026)
Table 12. Global Nuclear Medicine/Radiopharmaceutic (Kiloton) of Key Companies (2015-2020)
Table 13. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Company (2015-2020)
Table 14. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Company (2015-2020)
Table 16. Global Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2019)
Table 17. Global Nuclear Medicine/Radiopharmaceutic Average Price (US$/Ton) of Key Company (2015-2020)
Table 18. Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Sites and Area Served
Table 19. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceutic Players
Table 22. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 23. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2015-2020)
Table 24. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Nuclear Medicine/Radiopharmaceutic Price (Kiloton) by Type (2015-2020)
Table 26. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2021-2026)
Table 27. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2021-2026)
Table 29. Global Nuclear Medicine/Radiopharmaceutic Price (Kiloton) by Type (2021-2026)
Table 30. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2015-2020)
Table 31. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2015-2020)
Table 32. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Nuclear Medicine/Radiopharmaceutic Price (Kiloton) by Application (2015-2020)
Table 34. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2021-2026)
Table 35. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2021-2026)
Table 36. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2021-2026)
Table 38. Global Nuclear Medicine/Radiopharmaceutic Price (Kiloton) by Application (2021-2026)
Table 39. United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2015-2020)
Table 40. United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
Table 41. United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 42. United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 43. United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2015-2020)
Table 44. United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 45. Europe Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2015-2020)
Table 46. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
Table 47. Europe Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 48. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 49. Europe Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2015-2020)
Table 50. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 51. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2015-2020)
Table 52. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
Table 53. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 54. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 55. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2015-2020)
Table 56. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 57. Japan Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2015-2020)
Table 58. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
Table 59. Japan Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 60. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 61. Japan Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2015-2020)
Table 62. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2015-2020)
Table 64. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 66. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 68. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 69. India Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2015-2020)
Table 70. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2015-2020)
Table 71. India Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 72. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 73. India Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2015-2020)
Table 74. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 75. GE Healthcare Corporation Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 78. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product
Table 79. GE Healthcare Recent Development
Table 80. Bracco Imaging Corporation Information
Table 81. Bracco Imaging Description and Business Overview
Table 82. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 83. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 84. Bracco Imaging Recent Development
Table 85. Mallinckrodt Corporation Information
Table 86. Mallinckrodt Description and Business Overview
Table 87. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 88. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product
Table 89. Mallinckrodt Recent Development
Table 90. Lantheus Medical Imaging Corporation Information
Table 91. Lantheus Medical Imaging Description and Business Overview
Table 92. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 93. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 94. Lantheus Medical Imaging Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 98. Bayer Nuclear Medicine/Radiopharmaceutic Product
Table 99. Bayer Recent Development
Table 100. Jubilant Pharma Corporation Information
Table 101. Jubilant Pharma Description and Business Overview
Table 102. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 103. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product
Table 104. Jubilant Pharma Recent Development
Table 105. Nordion Corporation Information
Table 106. Nordion Description and Business Overview
Table 107. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 108. Nordion Nuclear Medicine/Radiopharmaceutic Product
Table 109. Nordion Recent Development
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 112. Eli Lilly Description and Business Overview
Table 113. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product
Table 114. Eli Lilly Recent Development
Table 115. SIEMENS Corporation Information
Table 116. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 117. SIEMENS Description and Business Overview
Table 118. SIEMENS Nuclear Medicine/Radiopharmaceutic Product
Table 119. SIEMENS Recent Development
Table 120. China Isotope & Radiation Corporation Information
Table 121. China Isotope & Radiation Description and Business Overview
Table 122. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 123. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product
Table 124. China Isotope & Radiation Recent Development
Table 125. Yantai Dongcheng Biochemicals Corporation Information
Table 126. Yantai Dongcheng Biochemicals Description and Business Overview
Table 127. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 128. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product
Table 129. Yantai Dongcheng Biochemicals Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Nuclear Medicine/Radiopharmaceutic Distributors List
Table 133. Nuclear Medicine/Radiopharmaceutic Customers List
Table 134. Nuclear Medicine/Radiopharmaceutic Market Key Trends
Table 135. Nuclear Medicine/Radiopharmaceutic Key Opportunities and Drivers
Table 136. Nuclear Medicine/Radiopharmaceutic Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2020 & 2026
Figure 6. Diagnostic Examples
Figure 7. Therapeutic Examples
Figure 8. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Growth Rate (2015-2026)
Figure 9. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Price Trends Growth Rate (2015-2026) (US$/Ton)
Figure 11. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Growth Rate (2015-2026)
Figure 15. Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Nuclear Medicine/Radiopharmaceutic Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Nuclear Medicine/Radiopharmaceutic Players Market Share by Revenue in Nuclear Medicine/Radiopharmaceutic 2015 & 2019
Figure 26. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2015-2020)
Figure 28. Global Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2015-2020)
Figure 30. Global Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 32. United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 33. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2019
Figure 34. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 35. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2019
Figure 36. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2019
Figure 37. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 38. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2019
Figure 39. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2019
Figure 40. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 41. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2019
Figure 42. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2019
Figure 43. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 44. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2019
Figure 45. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2019
Figure 46. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 47. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure 50. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure 51. Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
核エネルギーの世界市場レポート2020 Nuclear power is the use of nuclear reactions that release nuclear energy to generate heat, which most frequently is then used in steam turbines to produce electricity in a nuclear power plant. Nuclear power can be obtained from nuclear fission, nuclear decay and nuclear fusion. Nuclear energy techn…- 600MHz核磁気共鳴分光計の世界市場レポート2020 Nuclear magnetic resonance (NMR) spectrometer is the most powerful analytical tool currently available to an organic chemist. NMR allows characterization of a very small amount of sample (10mg), and does not destroy the sample (non-destructive technique). NMR spectra can provide vast information abo…
- 原子炉建設の世界市場レポート2020 Market Analysis and Insights: Global Nuclear Reactor Construction Market The global Nuclear Reactor Construction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Nuclear Reactor Construction Scope and Market Size The glo…
- 原子力LED照明の世界市場レポート2020 The Nuclear LED Lighting industry can be broken down into several segments, Emergency Light, High Bay Light, etc. At present, the number of nuclear power plants in the world has exceeded 400, of which the United States occupies a quarter. In the Nuclear LED Lighting market, the Europe region occupie…
- 廃炉の世界市場レポート2020 Market Analysis and Insights: Global Nuclear Decommissioning Market The global Nuclear Decommissioning market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Nuclear Decommissioning Scope and Market Size The global Nuclear Dec…